JP2009511076A - Ｌ−セリンの製造方法、遺伝子配列、ベクターおよび微生物 - Google Patents
Ｌ−セリンの製造方法、遺伝子配列、ベクターおよび微生物 Download PDFInfo
- Publication number
- JP2009511076A JP2009511076A JP2008535878A JP2008535878A JP2009511076A JP 2009511076 A JP2009511076 A JP 2009511076A JP 2008535878 A JP2008535878 A JP 2008535878A JP 2008535878 A JP2008535878 A JP 2008535878A JP 2009511076 A JP2009511076 A JP 2009511076A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- seq
- gene encoding
- serine
- corynebacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 title claims abstract description 76
- 108090000623 proteins and genes Chemical group 0.000 title claims abstract description 67
- 229960001153 serine Drugs 0.000 title claims abstract description 38
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 239000013598 vector Substances 0.000 title claims description 30
- 244000005700 microbiome Species 0.000 title claims description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 83
- 235000019152 folic acid Nutrition 0.000 claims abstract description 54
- 239000011724 folic acid Substances 0.000 claims abstract description 54
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 37
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229960000304 folic acid Drugs 0.000 claims abstract description 29
- 102000004190 Enzymes Human genes 0.000 claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 18
- 229940024606 amino acid Drugs 0.000 claims abstract description 11
- 150000001413 amino acids Chemical class 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 55
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 33
- 238000003786 synthesis reaction Methods 0.000 claims description 26
- 238000012217 deletion Methods 0.000 claims description 25
- 230000037430 deletion Effects 0.000 claims description 25
- 229940014144 folate Drugs 0.000 claims description 25
- 239000013612 plasmid Substances 0.000 claims description 18
- 230000035772 mutation Effects 0.000 claims description 15
- 230000004048 modification Effects 0.000 claims description 14
- 238000012986 modification Methods 0.000 claims description 14
- 241000186216 Corynebacterium Species 0.000 claims description 12
- 230000014509 gene expression Effects 0.000 claims description 11
- 108010073634 Aminodeoxychorismate lyase Proteins 0.000 claims description 10
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 10
- 241000186146 Brevibacterium Species 0.000 claims description 9
- 108010052434 Aminodeoxychorismate synthase Proteins 0.000 claims description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 6
- XGWIBNWDLMIPNF-UHFFFAOYSA-N 6-hydroxymethylpterin Chemical compound C1=C(CO)N=C2C(=O)NC(N)=NC2=N1 XGWIBNWDLMIPNF-UHFFFAOYSA-N 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 6
- BMQYVXCPAOLZOK-UHFFFAOYSA-N Trihydroxypropylpterisin Natural products OCC(O)C(O)C1=CN=C2NC(N)=NC(=O)C2=N1 BMQYVXCPAOLZOK-UHFFFAOYSA-N 0.000 claims description 6
- BMQYVXCPAOLZOK-XINAWCOVSA-N neopterin Chemical compound OC[C@@H](O)[C@@H](O)C1=CN=C2NC(N)=NC(=O)C2=N1 BMQYVXCPAOLZOK-XINAWCOVSA-N 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 239000001226 triphosphate Substances 0.000 claims description 5
- 235000011178 triphosphate Nutrition 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 claims description 4
- 241000337023 Corynebacterium thermoaminogenes Species 0.000 claims description 4
- YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 claims description 4
- ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 claims description 4
- 108090000856 Lyases Proteins 0.000 claims description 4
- 102000004317 Lyases Human genes 0.000 claims description 4
- 108010038555 Phosphoglycerate dehydrogenase Proteins 0.000 claims description 4
- 230000002238 attenuated effect Effects 0.000 claims description 4
- 101150002295 serA gene Proteins 0.000 claims description 4
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 4
- 241000305071 Enterobacterales Species 0.000 claims description 3
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 3
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 3
- 102000036509 GTP Cyclohydrolase Human genes 0.000 claims description 3
- 108010023555 GTP Cyclohydrolase Proteins 0.000 claims description 3
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- 102000009609 Pyrophosphatases Human genes 0.000 claims description 3
- 108010009413 Pyrophosphatases Proteins 0.000 claims description 3
- 108010022394 Threonine synthase Proteins 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 239000012190 activator Substances 0.000 claims description 3
- 230000003197 catalytic effect Effects 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- 102000004419 dihydrofolate reductase Human genes 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 108010076573 phosphoserine phosphatase Proteins 0.000 claims description 3
- 101150015622 pyk gene Proteins 0.000 claims description 3
- 101150060936 serB gene Proteins 0.000 claims description 3
- 108700028369 Alleles Proteins 0.000 claims description 2
- 102100023162 L-serine dehydratase/L-threonine deaminase Human genes 0.000 claims description 2
- 102100021762 Phosphoserine phosphatase Human genes 0.000 claims description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 claims description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 claims description 2
- 108091081024 Start codon Proteins 0.000 claims description 2
- 108010006873 Threonine Dehydratase Proteins 0.000 claims description 2
- 108010075344 Tryptophan synthase Proteins 0.000 claims description 2
- 230000006154 adenylylation Effects 0.000 claims description 2
- 230000003281 allosteric effect Effects 0.000 claims description 2
- 101150097303 glyA gene Proteins 0.000 claims description 2
- 101150095957 ilvA gene Proteins 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 101150117293 metC gene Proteins 0.000 claims description 2
- 230000026731 phosphorylation Effects 0.000 claims description 2
- 238000006366 phosphorylation reaction Methods 0.000 claims description 2
- 102000030592 phosphoserine aminotransferase Human genes 0.000 claims description 2
- 108010088694 phosphoserine aminotransferase Proteins 0.000 claims description 2
- 230000017854 proteolysis Effects 0.000 claims description 2
- 108020000318 saccharopine dehydrogenase Proteins 0.000 claims description 2
- 101150100082 sdaA gene Proteins 0.000 claims description 2
- 101150003830 serC gene Proteins 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 101150081616 trpB gene Proteins 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims 3
- JOAQINSXLLMRCV-UHFFFAOYSA-N 4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}benzoic acid Chemical compound C1=NC2=NC(N)=NC(O)=C2N=C1CNC1=CC=C(C(O)=O)C=C1 JOAQINSXLLMRCV-UHFFFAOYSA-N 0.000 claims 2
- 101710088194 Dehydrogenase Proteins 0.000 claims 1
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 description 13
- 238000013519 translation Methods 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 101150016334 pabAB gene Proteins 0.000 description 8
- 101150070572 pabC gene Proteins 0.000 description 8
- 229960004793 sucrose Drugs 0.000 description 8
- 238000010276 construction Methods 0.000 description 7
- 235000013681 dietary sucrose Nutrition 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 239000013611 chromosomal DNA Substances 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 5
- 206010016880 Folate deficiency Diseases 0.000 description 4
- 150000008575 L-amino acids Chemical class 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 239000007621 bhi medium Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 241000186031 Corynebacteriaceae Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- 108010019653 Pwo polymerase Proteins 0.000 description 2
- 101100378465 Streptomyces griseus pabAB gene Proteins 0.000 description 2
- 101100378467 Streptomyces venezuelae (strain ATCC 10712 / CBS 650.69 / DSM 40230 / JCM 4526 / NBRC 13096 / PD 04745) cmlB gene Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 241000186254 coryneform bacterium Species 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
- WTOFYLAWDLQMBZ-UHFFFAOYSA-N 2-azaniumyl-3-thiophen-2-ylpropanoate Chemical compound OC(=O)C(N)CC1=CC=CS1 WTOFYLAWDLQMBZ-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241001517047 Corynebacterium acetoacidophilum Species 0.000 description 1
- 102100037579 D-3-phosphoglycerate dehydrogenase Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108020005350 Initiator Codon Proteins 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000019394 Serine hydroxymethyltransferases Human genes 0.000 description 1
- 108010006152 Serine racemase Proteins 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229950011321 azaserine Drugs 0.000 description 1
- UUQMNUMQCIQDMZ-UHFFFAOYSA-N betahistine Chemical compound CNCCC1=CC=CC=N1 UUQMNUMQCIQDMZ-UHFFFAOYSA-N 0.000 description 1
- 230000001486 biosynthesis of amino acids Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/13—Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005049527A DE102005049527B4 (de) | 2005-10-17 | 2005-10-17 | Verfahren zur Herstellung von L-Serin, Gensequenz, Vektoren sowie Mikroorganismus |
| PCT/DE2006/001756 WO2007045210A1 (de) | 2005-10-17 | 2006-10-09 | Verfahren zur herstellung von l-serin, gensequenz, vektoren sowie mikroorganismus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009511076A true JP2009511076A (ja) | 2009-03-19 |
| JP2009511076A5 JP2009511076A5 (enExample) | 2009-10-08 |
Family
ID=37775257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008535878A Pending JP2009511076A (ja) | 2005-10-17 | 2006-10-09 | Ｌ−セリンの製造方法、遺伝子配列、ベクターおよび微生物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090181435A1 (enExample) |
| EP (1) | EP1937823A1 (enExample) |
| JP (1) | JP2009511076A (enExample) |
| KR (1) | KR20080049094A (enExample) |
| BR (1) | BRPI0617498A2 (enExample) |
| DE (1) | DE102005049527B4 (enExample) |
| WO (1) | WO2007045210A1 (enExample) |
| ZA (1) | ZA200804137B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10793826B2 (en) * | 2015-01-27 | 2020-10-06 | Cysbio Aps | Genetically modified microorganisms having improved tolerance towards L-serine |
| AU2017357813B2 (en) | 2016-11-11 | 2024-07-25 | Boehringer Ingelheim Vetmedica Gmbh | Attenuating bacterial virulence by attenuating bacterial folate transport |
| KR102869970B1 (ko) * | 2023-06-23 | 2025-10-14 | 씨제이제일제당 (주) | 변이된 rbs 염기 서열을 포함하는 폴리뉴클리오티드, 상기 폴리뉴클레오티드를 포함하는 미생물, 및 이를 이용한 글리신 생산 방법 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5372893A (en) * | 1976-12-08 | 1978-06-28 | Kyowa Hakko Kogyo Co Ltd | Preparation of l-serine by fermentation |
| JPH0556782A (ja) * | 1991-09-02 | 1993-03-09 | Kyowa Hakko Kogyo Co Ltd | 遺伝子発現調節ｄｎａ |
| JP2001112479A (ja) * | 1999-08-12 | 2001-04-24 | Ajinomoto Co Inc | コリネ型細菌で自律複製可能な新規プラスミド |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5212273B1 (enExample) * | 1970-05-06 | 1977-04-06 | ||
| CA1097240A (en) | 1976-11-30 | 1981-03-10 | Kiyoshi Nakayama | Process for production of l-serine |
| DE3580463D1 (de) * | 1984-12-27 | 1990-12-13 | Ajinomoto Kk | Verfahren zur herstellung von l-serine. |
| TW313589B (enExample) * | 1991-12-12 | 1997-08-21 | Wacker Chemie Gmbh | |
| JPH08107788A (ja) * | 1994-10-11 | 1996-04-30 | Mitsubishi Chem Corp | セリンヒドロキシメチルトランスフェラーゼをコードする遺伝子を含むｄｎａ断片 |
| JP4066543B2 (ja) * | 1998-01-12 | 2008-03-26 | 味の素株式会社 | 発酵法によるｌ−セリンの製造法 |
| JP3997631B2 (ja) * | 1998-01-12 | 2007-10-24 | 味の素株式会社 | 発酵法によるｌ−セリンの製造法 |
| DE19959329A1 (de) * | 1999-12-09 | 2001-06-13 | Degussa | Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien |
| DE10154292A1 (de) * | 2001-11-05 | 2003-05-15 | Basf Ag | Gene die für Stoffwechselweg-Proteine codieren |
| DE10311399A1 (de) * | 2003-03-13 | 2004-09-23 | Forschungszentrum Jülich GmbH | Nukleotidsequenzen coryneformer Bakterien codierend für am L-Serinstoffwechsel beteiligte Proteine sowie Verfahren zur mikrobiellen Herstellung von L-Serin |
-
2005
- 2005-10-17 DE DE102005049527A patent/DE102005049527B4/de not_active Expired - Lifetime
-
2006
- 2006-10-09 BR BRPI0617498-1A patent/BRPI0617498A2/pt not_active IP Right Cessation
- 2006-10-09 EP EP06805376A patent/EP1937823A1/de not_active Withdrawn
- 2006-10-09 JP JP2008535878A patent/JP2009511076A/ja active Pending
- 2006-10-09 KR KR1020087008076A patent/KR20080049094A/ko not_active Withdrawn
- 2006-10-09 US US12/083,662 patent/US20090181435A1/en not_active Abandoned
- 2006-10-09 WO PCT/DE2006/001756 patent/WO2007045210A1/de not_active Ceased
-
2008
- 2008-05-14 ZA ZA200804137A patent/ZA200804137B/xx unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5372893A (en) * | 1976-12-08 | 1978-06-28 | Kyowa Hakko Kogyo Co Ltd | Preparation of l-serine by fermentation |
| JPH0556782A (ja) * | 1991-09-02 | 1993-03-09 | Kyowa Hakko Kogyo Co Ltd | 遺伝子発現調節ｄｎａ |
| JP2001112479A (ja) * | 1999-08-12 | 2001-04-24 | Ajinomoto Co Inc | コリネ型細菌で自律複製可能な新規プラスミド |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007045210A1 (de) | 2007-04-26 |
| DE102005049527B4 (de) | 2013-05-08 |
| US20090181435A1 (en) | 2009-07-16 |
| ZA200804137B (en) | 2009-10-28 |
| DE102005049527A1 (de) | 2007-04-19 |
| KR20080049094A (ko) | 2008-06-03 |
| BRPI0617498A2 (pt) | 2011-07-26 |
| EP1937823A1 (de) | 2008-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4881739B2 (ja) | Ｌ−アルギニン、ｌ−オルニチンまたはｌ−シトルリンの製造法 | |
| JP2001149086A (ja) | 単離したポリヌクレオチド、複製可能なｄｎａ、ポリヌクレオチド配列、ベクター、宿主細胞として使用されるコリネフォルム細菌、およびｌ−アミノ酸の発酵による製造法 | |
| US20050196848A1 (en) | Process for the fermentative production of L-amino acids by attenuation of the poxB gene | |
| EP2841568B1 (en) | Feedback-resistant alpha-isopropylmalate synthases | |
| CN1288058A (zh) | 编码pgi基因的新核苷酸序列 | |
| DK200900060U3 (da) | Nukleotidsekvenser fra coryneforme bakterier som koder for proteiner der deltager i L-serinstofskiftet | |
| JP2001197892A (ja) | ｚｗａ２遺伝子をコードする新規ヌクレオチド配列 | |
| CN100523197C (zh) | 反馈抗性乙酰羟酸合成酶突变体 | |
| EP3498854B1 (en) | Method for the fermentative production of l-lysine | |
| JP5227789B2 (ja) | Ｌ−アミノ酸の発酵的製造方法 | |
| HUP0303926A2 (hu) | Eljárás aminosavak fermentációs úton történő előállítására corynebacteriumok alkalmazásával | |
| CN111471631A (zh) | 发酵产生l-赖氨酸的方法 | |
| JP2009511076A (ja) | Ｌ−セリンの製造方法、遺伝子配列、ベクターおよび微生物 | |
| KR20080052593A (ko) | 미생물을 사용한 아미노산 생산 방법 | |
| HUP0004414A2 (en) | Process for the fermentative production of l-lysine using coryneform bacteria | |
| JP2008514191A (ja) | 増加したトランスアミナーゼｃ活性を有するコリネバクテリウム・グルタミカム株を使用するｌ−バリンの発酵的製造方法。 | |
| JP2006524032A (ja) | コリネ型バクテリアの脱調節されたホスホグリセラート−デヒドロゲナーゼをコードするヌクレオチド配列並びにｌ−セリンの製造方法 | |
| US7132272B2 (en) | Nucleotide sequence encoding corynebacterium glutamicum leucine response regulatory protein | |
| US20120034669A1 (en) | Process for producing useful substance | |
| US20030148476A1 (en) | Nucleotide sequences that code for the rplK gene and methods of use thereof | |
| WO2002008437A2 (en) | Process for the fermentative preparation of l-glutamic acid using coryneform bacteria | |
| KR20010095300A (ko) | ｒｐｌＫ 유전자를 암호화하는 뉴클레오타이드 서열 및이의 사용 방법 | |
| KR20060129352A (ko) | ｚｗｆ 유전자의 증폭을 이용한 Ｌ-아미노산의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20090821 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090821 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100518 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120307 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120925 |